Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-005207
Filing Date
2019-05-20
Accepted
2019-05-20 16:21:11
Documents
68
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hook-20190331x10q.htm 10-Q 1987491
2 EX-10.1 hook-20190331ex10132aac3.htm EX-10.1 20023
3 EX-31.1 hook-20190331ex311bcdcb3.htm EX-31.1 12128
4 EX-31.2 hook-20190331ex312bac31d.htm EX-31.2 12143
5 EX-32.1 hook-20190331ex321981df2.htm EX-32.1 12457
  Complete submission text file 0001558370-19-005207.txt   6560756

Data Files

Seq Description Document Type Size
6 EX-101.INS hook-20190331.xml EX-101.INS 1256240
7 EX-101.SCH hook-20190331.xsd EX-101.SCH 54315
8 EX-101.CAL hook-20190331_cal.xml EX-101.CAL 62455
9 EX-101.DEF hook-20190331_def.xml EX-101.DEF 140899
10 EX-101.LAB hook-20190331_lab.xml EX-101.LAB 451483
11 EX-101.PRE hook-20190331_pre.xml EX-101.PRE 313634
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

EIN.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38869 | Film No.: 19839024
SIC: 2834 Pharmaceutical Preparations